Handelsbanken Fonder Ab Guardant Health, Inc. Transaction History

Handelsbanken Fonder Ab

$25.3 Billion
Q3 2024

A detailed history of Handelsbanken Fonder Ab transactions in Guardant Health, Inc. stock. As of the latest transaction made, Handelsbanken Fonder Ab holds 27,141 shares of GH stock, worth $856,841. This represents 0.0% of its overall portfolio holdings.

Number of Shares

27,141

Previous 23,641 14.8%

Holding current value

$856,841

Previous $683,000 8.78%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 04, 2024	BUY	$22.3 - $36.29 $78,050 - $127,015	3,500 Added 14.8%	27,141 $623,000
Q2 2024 Aug 05, 2024	SELL	$16.07 - $31.84 $3.35 Million - $6.65 Million	-208,700 Reduced 89.82%	23,641 $683,000
Q1 2024 May 13, 2024	BUY	$17.13 - $26.91 $1.22 Million - $1.91 Million	71,000 Added 44.01%	232,341 $4.79 Million
Q4 2023 Feb 01, 2024	BUY	$21.58 - $29.5 $839,461 - $1.15 Million	38,900 Added 31.77%	161,341 $4.36 Million
Q3 2023 Oct 19, 2023	BUY	$25.8 - $39.97 $215,197 - $333,389	8,341 Added 7.31%	122,441 $3.63 Million
Q2 2023 Aug 02, 2023	BUY	$20.94 - $38.01 $27,222 - $49,413	1,300 Added 1.15%	114,100 $4.09 Million
Q4 2022 Feb 07, 2023	BUY	$25.44 - $59.78 $2,544 - $5,978	100 Added 0.09%	112,800 $3.07 Million
Q2 2022 Aug 03, 2022	BUY	$28.82 - $77.35 $37,466 - $100,554	1,300 Added 1.17%	112,700 $4.55 Million
Q1 2022 May 11, 2022	BUY	$48.25 - $100.49 $2.19 Million - $4.56 Million	45,400 Added 68.79%	111,400 $7.38 Million
Q4 2021 Feb 08, 2022	SELL	$88.71 - $120.43 $381,453 - $517,849	-4,300 Reduced 6.12%	66,000 $6.6 Million
Q3 2021 Nov 10, 2021	BUY	$98.77 - $132.17 $158,032 - $211,471	1,600 Added 2.33%	70,300 $8.79 Million
Q2 2021 Aug 03, 2021	SELL	$109.77 - $165.68 $1.04 Million - $1.57 Million	-9,500 Reduced 12.15%	68,700 $8.53 Million
Q1 2021 Apr 29, 2021	BUY	$127.04 - $179.1 $2.5 Million - $3.53 Million	19,700 Added 33.68%	78,200 $11.9 Million
Q4 2020 Feb 11, 2021	SELL	$99.96 - $135.93 $259,895 - $353,418	-2,600 Reduced 4.26%	58,500 $7.54 Million
Q3 2020 Nov 13, 2020	BUY	$80.32 - $111.8 $602,400 - $838,500	7,500 Added 13.99%	61,100 $6.83 Million
Q2 2020 Aug 13, 2020	BUY	$60.49 - $97.5 $641,194 - $1.03 Million	10,600 Added 24.65%	53,600 $4.35 Million
Q4 2019 Feb 14, 2020	BUY	$59.49 - $82.78 $594,900 - $827,800	10,000 Added 30.3%	43,000 $3.36 Million
Q3 2019 Oct 31, 2019	SELL	$62.59 - $110.3 $3.76 Million - $6.62 Million	-60,000 Reduced 64.52%	33,000 $2.11 Million
Q2 2019 Jul 12, 2019	BUY	$63.94 - $91.11 $5.95 Million - $8.47 Million	93,000 New	93,000 $8.03 Million

Others Institutions Holding GH

# of Institutions

323

Shares Held

127M

Call Options Held

844K

Put Options Held

2.38M

View Full List

About Guardant Health, Inc.

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.23B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

More about GH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Handelsbanken Fonder Ab, based on Form 13F filings with the SEC.

News

Stay updated on Handelsbanken Fonder Ab with notifications on news.

Account

Handelsbanken Fonder Ab Guardant Health, Inc. Transaction History